Page last updated: 2024-08-25

rosiglitazone and Nodular Goiter

rosiglitazone has been researched along with Nodular Goiter in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Annunziato, F; Borgogni, E; Cosmi, L; Crescioli, C; Francalanci, M; Gelmini, S; Mazzinghi, B; Perigli, G; Pezzatini, A; Santarlasci, V; Sarchielli, E; Serio, M; Sottili, M; Vannelli, GB	1

Other Studies

1 other study(ies) available for rosiglitazone and Nodular Goiter

Article	Year
Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes. The Journal of endocrinology, 2007, Volume: 195, Issue:1 Topics: Antithyroid Agents; Cells, Cultured; Chemokine CXCL10; Depression, Chemical; Flow Cytometry; Goiter, Nodular; Humans; Interferon-gamma; Methimazole; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Thyroid Gland; Tumor Necrosis Factor-alpha	2007

Article

Year

Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes.

The Journal of endocrinology, 2007, Volume: 195, Issue:1

Topics: Antithyroid Agents; Cells, Cultured; Chemokine CXCL10; Depression, Chemical; Flow Cytometry; Goiter, Nodular; Humans; Interferon-gamma; Methimazole; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Thyroid Gland; Tumor Necrosis Factor-alpha

2007